| Sep'19 | Sep'18 | Sep'17 | Sep'16 | Sep'15 | Sep'14 | Sep'13 | Sep'12 | Sep'11 | Sep'10 | Sep'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||||||
Net income | ||||||||||
437,416 | 116,464 | 62,612 | -69,476 | 14,221 | 31,522 | -2,150 | 136,835 | 130,437 | 59,884 | -227,773 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
Depreciation and amortization | ||||||||||
54,454 | 37,429 | 28,149 | 28,046 | 25,160 | 23,459 | 24,155 | 21,620 | 17,249 | 18,420 | 25,856 |
Gain on settlement of equity method investment | ||||||||||
- | - | 1,847 | - | - | - | - | - | - | - | - |
Impairment of property, plant and equipment | ||||||||||
285 | - | - | 807 | - | 2,621 | 0 | 0 | - | - | - |
Impairment of intangible assets | ||||||||||
- | - | - | - | - | 398 | 1,960 | 0 | 0 | - | 107,312 |
Stock-based compensation | ||||||||||
20,113 | 19,822 | 17,278 | 11,737 | 12,159 | 10,912 | 7,757 | 8,647 | 6,752 | 6,567 | 5,817 |
Amortization of premium on marketable securities and deferred financing costs | ||||||||||
-1,121 | -710 | -252 | -339 | -1,193 | -1,255 | -1,274 | -2,401 | 2,283 | -942 | -127 |
Earnings of equity method investments | ||||||||||
6,188 | 6,788 | 9,381 | 2,380 | -164 | 1,235 | 2,442 | 2,133 | 4,815 | 1,074 | -213 |
Loss recovery on insurance claim | ||||||||||
- | 1,103 | - | - | - | - | - | - | - | - | - |
Deferred income taxes | ||||||||||
-15,161 | -45,217 | 517 | 70,273 | -2,173 | -1,779 | -2,936 | -122,136 | -276 | - | - |
Loss on extinguishment of debt | ||||||||||
-14,339 | - | - | - | - | - | - | - | - | - | - |
Loss on write-downs of assets held for sale | ||||||||||
- | - | - | - | 1,944 | 0 | 0 | - | - | - | - |
Pension settlement | ||||||||||
- | - | 300 | - | -232 | 0 | 87 | 8,937 | 0 | - | - |
Other losses on disposals of assets | ||||||||||
-209 | 758 | 406 | 41 | 85 | 27,444 | 0 | 0 | 45,009 | - | - |
Loss on sale of divestiture, net of tax | ||||||||||
408,575 | - | - | - | - | - | - | - | - | - | - |
Contingent transaction fees paid stemming from divestiture | ||||||||||
13,388 | - | - | - | - | - | - | - | - | - | - |
Gain on disposal of long-lived assets | ||||||||||
- | - | - | - | - | -13 | 1,394 | 63 | -10 | -4 | -17 |
Changes in operating assets and liabilities, net of acquisitions and divestiture: | ||||||||||
Loss on investment | ||||||||||
- | - | - | - | - | - | - | - | - | 191 | 1,185 |
Gain on sale of intellectual property rights | ||||||||||
- | - | - | - | - | - | - | - | - | 7,840 | - |
Accounts receivable | ||||||||||
11,445 | 28,463 | 11,178 | 1,796 | 5,134 | -12,098 | -6,422 | 784 | -9,916 | 53,163 | -29,963 |
Inventories | ||||||||||
2,933 | 24,365 | 12,792 | -8,565 | 5,919 | -9,598 | -15,490 | -5,874 | 19,131 | 31,341 | -21,779 |
Prepaid expenses and other assets | ||||||||||
16,009 | 3,676 | 5,829 | 428 | 2,875 | 12,325 | -4,359 | -5,801 | -4,205 | 499 | -4,527 |
Accounts payable | ||||||||||
4,695 | 5,457 | 7,846 | -5,143 | 8,358 | -11,924 | 3,123 | -11,182 | -15,099 | 39,352 | -10,947 |
Deferred revenue | ||||||||||
4,213 | 2,791 | 8,049 | -3,290 | -6,779 | 5,900 | 8,971 | -4,684 | 1,841 | 1,487 | -676 |
Accrued warranty and retrofit costs | ||||||||||
1,109 | -157 | 1,602 | 290 | -407 | -1,102 | -1,806 | -123 | -1,420 | 2,483 | -2,496 |
Accrued compensation and tax withholdings | ||||||||||
-6,453 | 5,978 | 5,565 | -3,234 | -1,148 | 6,783 | -2,625 | -4,878 | 1,717 | -755 | -3,869 |
Accrued restructuring costs | ||||||||||
399 | -1,080 | -4,241 | 3,860 | -1,247 | 2,161 | -972 | 1,930 | -3,212 | -4,123 | -5,007 |
Accrued pension costs | ||||||||||
- | - | -32 | -811 | 812 | 997 | -950 | -5,772 | 2,014 | -2,605 | - |
Proceeds from recovery on insurance claim | ||||||||||
1,082 | - | - | - | - | - | - | - | - | - | - |
Accrued expenses and other liabilities | ||||||||||
31,615 | -3,080 | 10,319 | 2,229 | 5,251 | 1,873 | -3,934 | -4,252 | 188 | -58 | -2,522 |
Net cash (used in) provided by operating activities | ||||||||||
90,898 | 73,964 | 96,224 | 39,547 | 43,727 | 53,781 | 54,389 | 36,038 | 87,650 | 27,872 | -56,494 |
Cash flows from investing activities | ||||||||||
Purchases of property, plant and equipment | ||||||||||
23,861 | 12,787 | 12,677 | 12,848 | 16,146 | 5,518 | 3,635 | 8,653 | 6,455 | 3,472 | 11,339 |
Proceeds from the sale of intellectual property rights | ||||||||||
- | - | - | - | - | - | - | - | - | 7,840 | - |
Purchases of technology intangibles | ||||||||||
- | - | 240 | - | - | - | - | - | - | 892 | - |
Purchases of marketable securities | ||||||||||
35,225 | 69,692 | - | 12,901 | 87,333 | 174,287 | 91,740 | 132,015 | 186,718 | 117,473 | 59,091 |
Sales of marketable securities | ||||||||||
48,900 | 1,600 | 3,590 | 139,388 | 104,008 | 112,085 | 145,023 | 131,317 | 120,095 | 84,546 | 75,628 |
Maturities of marketable securities | ||||||||||
2,557 | 17,482 | - | - | - | - | - | - | - | - | - |
Proceeds from divestiture | ||||||||||
661,642 | - | - | - | - | - | - | - | - | - | - |
Disbursement for a loan receivable | ||||||||||
- | - | - | 1,821 | - | 0 | - | - | - | - | - |
Proceeds from divestitures | ||||||||||
- | - | - | - | - | - | - | - | -181 | -243 | -1,055 |
Acquisitions, net of cash acquired | ||||||||||
442,704 | 85,755 | 44,791 | 125,248 | 14,450 | 35,625 | 68,331 | 9,216 | 88,309 | - | - |
Proceeds from divestitures | ||||||||||
- | - | - | - | - | 85,369 | 0 | 0 | 78,249 | - | - |
Proceeds from liquidation of a joint venture | ||||||||||
- | - | - | - | 1,778 | 0 | 0 | - | - | - | - |
Decrease in restricted cash | ||||||||||
- | - | - | - | - | -177 | -586 | -530 | 1,293 | - | - |
Purchase of other investments | ||||||||||
- | 500 | 170 | 250 | 5,500 | 0 | 0 | 3,000 | 0 | - | - |
Proceeds from sales of property, plant and equipment | ||||||||||
- | 200 | 100 | 2,806 | 6 | 0 | 14,082 | 0 | 0 | - | - |
Payments of deferred leasing costs | ||||||||||
- | - | - | - | - | - | 3,134 | 0 | 0 | - | - |
Net cash used in investing activities | ||||||||||
211,312 | -148,468 | -54,188 | -10,874 | -17,637 | -17,799 | -7,149 | -21,037 | -84,250 | -29,208 | 6,253 |
Cash flows from financing activities | ||||||||||
Proceeds from term loans, net of discount | ||||||||||
686,386 | 197,554 | - | 366 | - | - | - | - | - | - | - |
Proceeds from line of credit | ||||||||||
- | - | - | - | - | 0 | - | - | - | - | - |
Proceeds from issuance of common stock | ||||||||||
3,422 | 2,826 | 2,040 | 1,888 | 1,807 | 1,838 | 1,851 | 1,705 | 1,358 | 1,245 | 1,248 |
Payments of financing costs | ||||||||||
687 | 318 | 28 | 708 | - | 0 | - | - | - | - | - |
Principal payments on debt | ||||||||||
850,190 | 1,500 | - | - | - | - | - | - | - | - | - |
Payments of capital leases | ||||||||||
1,197 | - | - | - | - | 239 | 0 | 0 | - | - | - |
Acquisitions of noncontrolling interest | ||||||||||
- | - | - | - | - | 3,189 | 0 | 0 | - | - | - |
Repayment of debt assumed in business acquisition | ||||||||||
- | - | - | - | 8,829 | 0 | 0 | - | - | - | - |
Common stock dividends paid | ||||||||||
28,895 | 28,285 | 27,932 | 27,503 | 26,992 | 22,875 | 21,328 | 20,953 | 5,180 | - | - |
Net cash (used in) provided by financing activities | ||||||||||
-191,161 | 170,277 | -25,920 | -25,957 | -34,014 | -24,465 | -19,477 | -19,248 | -3,822 | 1,245 | 1,248 |
Effects of exchange rate changes on cash and cash equivalents | ||||||||||
-3,586 | 313 | 420 | 1,648 | -5,468 | -374 | 569 | 53 | -568 | -71 | -1,291 |
Net decrease in cash, cash equivalents and restricted cash | ||||||||||
107,463 | 96,086 | 16,536 | 4,364 | -13,392 | 11,143 | 28,332 | -4,194 | -990 | -162 | -50,284 |
Supplemental disclosures: | ||||||||||
Cash paid for interest | ||||||||||
20,799 | 6,537 | 200 | 114 | 395 | 202 | 2 | 14 | 65 | 80 | 454 |
Cash paid for income taxes, net | ||||||||||
16,990 | 21,051 | 8,142 | 4,930 | 3,883 | 1,084 | -762 | 4,282 | 1,042 | -1,866 | 246 |
Supplemental disclosure of non-cash investing and financing activities: | ||||||||||
Acquisition of buildings and land through capital lease | ||||||||||
- | - | - | - | - | 8,537 | 0 | 0 | - | - | - |
Derecognition of a capital lease obligation and the related assets | ||||||||||
- | - | - | - | 7,804 | 0 | 0 | - | - | - | - |
Deferred financing costs included in accounts payable | ||||||||||
- | - | 423 | - | - | - | - | - | - | - | - |
Fair value of non-cash consideration for the acquisition of Cool Lab, LLC | ||||||||||
- | - | 10,348 | - | - | - | - | - | - | - | - |